“This is reminiscent of the ADE (antibody dependent enhancement) phenomenon that has been seen for other vaccine and that has been expressed as a point of concern among many scientists for the COVID vaccines,” experienced researcher Stephanie Seneff at Massachusetts Institute of Technology’s Computer Science and Artificial Intelligence Laboratory told LifeSiteNews.
Earlier efforts with CCP Virus vaccines were hampered by ADE, which typically resulted in increased lung illness in injected lab animals. It prompted experts to advise scientists in 2012 to proceed with “caution” while developing human CCP Virus vaccines that could cause increased lung illness.
“I also suspect that massive vaccination campaigns may accelerate the rate at which the vaccine-resistant mutant strains become dominant among all the SARS-Co-V2 [coronavirus] strains.” Seneff stated.
There were 26 deaths out of 4,087 patients who were fully vaccinated 14 days or more before testing positive for the Delta CCP Virus strain. According to data released in a June 18 report titled “SARS-CoV-2 variants of concern and variants under investigation in England, Technical briefing 16,” this compared to a death rate of 0.00636 %, which was 6.6 times higher than the rate of 0.000957 %—or 34 deaths among 35,521 positive Delta cases among those who did not get a shot.
For Delta, a version that PHE identifies as the “dominant variant” in the UK, encompassing “91 percent of sequenced cases,” both mortality rates among the unvaccinated and vaccinated were extremely low (less than 1 % of all positive cases).
The Delta version of the CCP Virus pandemic was defined as more easily disseminated between people in a risk analysis issued on Friday, June 18, but it was also classified as a variety with “low infection severity.”
Completely vaccinated individuals were hospitalized at a higher rate than unvaccinated people in the UK. Two percent of vaccinated patients (84 of 4,087) who tested positive for the Delta variant were admitted to hospital, compared to 1.48 % of unvaccinated ones (527 of 35,521), according to the most recent technical briefing report.
According to PHE’s current risk assessment for SARS-C0V-2 variations, a shocking 61 % of the cases sequenced were the Delta form (B.1.617.2). This indicated that the Delta variant, which was initially discovered in India, is more prevalent in the UK than the Alpha form, which caused a spike last year.
It was classified as a variation of concern by the World Health Organization (WHO), which has gave it the name Delta (VOC). It continued to see “significantly increased transmissibility” and a “growing number of countries reporting outbreaks associated with this variant,” WHO reported.
People completely vaccinated with the Pfizer-BioNTech vaccine have more than five times lower levels of neutralizing antibodies against the Delta variant than against other versions, according to a report published in The Lancet on Friday, June 11.